These clinical, radiologic and laboratory findings were consistent with a diagnosis of idiopathic central precocious puberty; therefore, GnRH analog therapy was started, in order to slow pubertal progression and to preserve maximum adult stature [5,16]. This evidence concerns the gene GNRH1 and central precocious puberty.